<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/"><channel><title>医学新闻</title><description>来自 News-Medical.Net - 来自世界各地的最新医学新闻和研究</description><link/>https://www.news-medical.net/<language> en-GB</language><item><title>服用血压药物的时间不会影响结果</title><description>今天在 2024 年 ESC 大会热线会议上公布的最新研究表明，与早晨服用降血压药物相比，晚上服用降血压药物并不能降低心血管事件或死亡的风险。</description><link/> https://www.news-medical.net/news/20240901/Timing-of-blood-Pressure-medication-administration-does-not-affect-outcomes.aspx<comments> https://www.news-medical.net/news/20240901/Timing-of-blood-Pressure-medication-administration-does-not-affect-outcomes.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=18a16c27-4381-45f2-8584-3bdbe712d59f</guid><pubDate> Sun, 01 Sep 2024 14:13:06 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2016/3/Blood_pressure_-_kurhan_190c9e39c9604c7a8ce4b5999522f80a-620x480.jpg" width="620"><media:description><![CDATA[Timing of blood pressure medication administration does not affect outcomes]]></media:description></media:content></item><item><title>低剂量三药组合对尼日利亚成年人血压控制的效果优于标准护理</title><description>根据今天在 ESC 热线会议上发表的最新研究成果，对于高血压未得到控制的非洲尼日利亚黑人成年人来说，基于低剂量三联单药组合的方案比标准护理方案能更好地控制血压 (BP) 2024 年国会。</description><link/> https://www.news-medical.net/news/20240901/Low-dose-triple-pill-combination-outperforms-standard-care-for-blood-Pressure-control-in-Nigerian-adults.aspx<comments> https://www.news-medical.net/news/20240901/Low-dose-triple-pill-combination-outperforms-standard-care-for-blood-Pressure-control-in-Nigerian-adults.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=55e3ea11-013b-43d5-bf87-932dc47dd09a</guid><pubDate> Sun, 01 Sep 2024 14:07:46 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2017/4/Blood_pressure_measuring-Sappasit_c7dd0e34690648c9b114f8414f59e269-620x480.jpg" width="620"><media:description><![CDATA[Low-dose triple-pill combination outperforms standard care for blood pressure control in Nigerian adults]]></media:description></media:content></item><item><title> MATTERHORN 试验发现 TEER 治疗继发性二尖瓣反流并不逊色于手术</title><description>根据今日 ESC 2024 年大会热线会议上公布的最新研究结果，对于继发性二尖瓣反流 (MR) 患者，经导管边对边修复 (TEER) 和手术的疗效没有差异。</description><link/> https://www.news-medical.net/news/20240901/MATTERHORN-trial-finds-TEER-non-inferior-to-surgery-for-secondary-mitral-regurgitation.aspx<comments> https://www.news-medical.net/news/20240901/MATTERHORN-trial-finds-TEER-non-inferior-to-surgery-for-secondary-mitral-regurgitation.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=6c178e18-b16b-43b6-82b8-98424a18dbef</guid><pubDate> Sun, 01 Sep 2024 14:00:14 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2014/7/heart-620x480.jpg" width="620"><media:description><![CDATA[MATTERHORN trial finds TEER non-inferior to surgery for secondary mitral regurgitation]]></media:description></media:content></item><item><title>在 CABG 中，非接触式移植物采集与传统技术相比没有优势</title><description>根据今日 ESC 2024 年大会热线会议上公布的最新研究成果，与传统的冠状动脉旁路移植术 (CABG) 技术相比，非接触式移植物采集似乎没有什么好处。</description><link/> https://www.news-medical.net/news/20240901/No-touch-graft-harvesting-shows-no-advantage-over-conventional-technique-in-CABG.aspx<comments> https://www.news-medical.net/news/20240901/No-touch-graft-harvesting-shows-no-advantage-over-conventional-technique-in-CABG.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=f4a6346e-2b42-4f4b-82dd-831a3cb477c8</guid><pubDate> Sun, 01 Sep 2024 13:54:06 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2014/7/Heart_Disease-620x480.jpg" width="620"><media:description><![CDATA[No-touch graft harvesting shows no advantage over conventional technique in CABG]]></media:description></media:content></item><item><title> T-TEER 在严重三尖瓣反流患者一年后显示出有希望的结果</title><description>根据今日 ESC 2024 年大会热线会议上公布的最新研究成果，经导管三尖瓣边缘修复术 (T-TEER) 显着降低了继发性三尖瓣反流的严重程度，并提高了一年后的生活质量。</description><link/> https://www.news-medical.net/news/20240901/T-TEER-shows-promising-outcomes-in-severe-tricuspid-regurgitation-病人-after-one-year.aspx<comments> https://www.news-medical.net/news/20240901/T-TEER-shows-promising-outcomes-in-severe-tricuspid-regurgitation-病人-after-one-year.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=08adec8a-f08f-457c-ad82-d03b8f25cb21</guid><pubDate> Sun, 01 Sep 2024 13:48:56 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2014/7/Fatigue-620x480.jpg" width="620"><media:description><![CDATA[T-TEER shows promising outcomes in severe tricuspid regurgitation patients after one year]]></media:description></media:content></item><item><title>研究表明药物洗脱支架植入后采用灵活的抗血小板管理方法</title><description>最新研究表明，在冠状动脉药物洗脱支架 (DES) 植入后 1 年以上接受非心脏手术的患者中，围术期阿司匹林单药治疗与不接受抗血小板治疗之间的缺血结局或大出血没有差异今天在 ESC 2024 年大会的热线会议上提出。</description><link/> https://www.news-medical.net/news/20240901/Research-suggests-flexible-approach-to-antiplatelet-management-after-coronary-drug-eluting-stent-implantation.aspx<comments> https://www.news-medical.net/news/20240901/Research-suggests-flexible-approach-to-antiplatelet-management-after-coronary-drug-eluting-stent-implantation.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=6476176e-ae8a-4a70-8192-333cc3eb299d</guid><pubDate> Sun, 01 Sep 2024 13:37:00 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2014/7/Aspirin-620x480.jpg" width="620"><media:description><![CDATA[Research suggests flexible approach to antiplatelet management after drug-eluting stent implantation]]></media:description></media:content></item><item><title> TAVI 在减少严重主动脉瓣狭窄女性并发症方面优于手术</title><description>根据今日 ESC 2024 年大会热线会议上公布的最新研究结果，经导管主动脉瓣植入 (TAVI) 在减少严重主动脉瓣狭窄女性的死亡、中风或再住院方面优于手术主动脉瓣置换术。</description><link/> https://www.news-medical.net/news/20240901/TAVI-outperforms-surgery-in-reducing-complications-for-women-with-severe-aortic-stenosis.aspx<comments> https://www.news-medical.net/news/20240901/TAVI-outperforms-surgery-in-reducing-complications-for-women-with-severe-aortic-stenosis.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=c2dff0f9-5551-4548-a54c-d07b688a66a5</guid><pubDate> Sun, 01 Sep 2024 13:23:00 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2014/7/Stroke-620x480.jpg" width="620"><media:description><![CDATA[TAVI outperforms surgery in reducing complications for women with severe aortic stenosis]]></media:description></media:content></item><item><title>研究发现冠状动脉搭桥术后常规补钾没有额外益处</title><description>对于预防孤立性冠状动脉搭桥术（CABG）术后新发心房颤动（AF），仅在水平降至正常下限以下时补充钾并不劣于常规补充钾至正常上限，根据今日 ESC 2024 年大会热线会议上公布的最新研究成果。</description><link/> https://www.news-medical.net/news/20240901/Study-finds-no-added-benefit-to-routine-potassium-supplementation-after-CABG.aspx<comments> https://www.news-medical.net/news/20240901/Study-finds-no-added-benefit-to-routine-potassium-supplementation-after-CABG.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=ac748288-3b29-4393-ac78-5049e30b908c</guid><pubDate> Sun, 01 Sep 2024 13:16:04 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2017/9/shutterstock_355383182_549c285dbfbb49519b7f2f949219511a-620x480.jpg" width="620"><media:description><![CDATA[Study finds no added benefit to routine potassium supplementation after CABG]]></media:description></media:content></item><item><title> TAVI 患者持续口服抗凝药没有任何益处</title><description>今天在 ESC 2024 年大会热线会议上发表的最新研究显示，对于接受经导管主动脉瓣植入 (TAVI) 的患者来说，持续口服抗凝药物与中断口服抗凝药物相比并没有明显的益处。</description><link/> https://www.news-medical.net/news/20240901/TAVI-病人-show-no-benefit-from-continuing-oral-anticoagulants.aspx<comments> https://www.news-medical.net/news/20240901/TAVI-病人-show-no-benefit-from-continuing-oral-anticoagulants.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=8f49f7e9-dfa4-4d0e-b6c9-8cde0275a444</guid><pubDate> Sun, 01 Sep 2024 13:09:00 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2019/9/Products_containing_potassium_peas%2c_walnuts%2c_beans%2c_parsley%2c_basil%2c_egg_yolk%2c_d_-_Elena_Hramova_M1_941f61af4e8e4d69a5663bde0faacd7d-620x480.jpg" width="620"><media:description><![CDATA[TAVI patients show no benefit from continuing oral anticoagulants]]></media:description></media:content></item><item><title>患有冠状动脉疾病的 TAVI 患者可以从经皮冠状动脉介入治疗中获益</title><description>根据今日在 ESC 大会热线会议上发表的最新研究成果，经皮冠状动脉介入治疗 (PCI) 显着改善了选择接受经导管主动脉瓣植入 (TAVI) 的稳定型冠状动脉疾病 (CAD) 和严重主动脉瓣狭窄患者的预后2024 年。</description><link/> https://www.news-medical.net/news/20240901/TAVI-患者-with-coronary-artery-disease-can-derive-benefits-from-perderma-coronary-intervention.aspx<comments> https://www.news-medical.net/news/20240901/TAVI-患者-with-coronary-artery-disease-can-derive-benefits-from-perderma-coronary-intervention.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=afc7e60d-8676-4cd5-9dc6-e2b5ab5110c0</guid><pubDate> Sun, 01 Sep 2024 13:04:00 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2014/7/Coronary_Artery_Disease-620x480.jpg" width="620"><media:description><![CDATA[TAVI patients with coronary artery disease can derive benefits from percutaneous coronary intervention]]></media:description></media:content></item></channel></rss>